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ABSTRACT
Objective: Robust scientific and clinical evidence of how to appropriately manage denture
plaque is lacking. This two-part study (i) developed an in vitro model of denture plaque
removal, and (ii) assessed effectiveness of these approaches in a randomised clinical trial.
Method: (i) a complex denture plaque model was developed using the dominant microbial
genera from a recent microbiome analyses. Biofilms formed on polymethylmethacrylate were
brushed daily with a wet toothbrush, then either treated daily for 5 days or only on Days 1 and
5 with Polident® denture cleanser tablets (3 min soaking). Quantitative and qualitative micro-
biological assessments were performed. (ii), an examiner-blind, randomised, crossover study of
complete maxillary denture wearers was performed (n = 19). Either once-daily for 7 days or on
Day 7 only, participants soaked dentures for 15 min using Corega® denture cleansing tables,
then brushed. Denture plaque microbiological assessment used sterilized filter paper discs.
Results: The in vitro model showed daily cleaning with denture cleanser plus brushing
significantly reduced microbial numbers compared to intermittent denture cleaning with
daily brushing (p < 0.001). The clinical component of the study showed a statistically
significant reduction in denture plaque microbial numbers in favour of daily versus weekly
treatment (aerobic bacteria p = 0.0144). Both in vitro and in vivo studies showed that denture
plaque biofilm composition were affected by different treatment arms.
Conclusions: This study demonstrated that daily denture cleansing regimens are superior to
intermittent denture cleansing, and that cleansing regimens can induce denture plaque
compositional changes. Clinicaltrials.gov registration: NCT02780661.
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As the elderly population expands to a predicted two
billion by 2050, the number of denture wearers will
continue to rise. Edentulousness (loss of all teeth) is
an irreversible clinical condition that can be
described as an ultimate marker of oral disease bur-
den [1]. Currently, around 20% of the UK population
wear removable dentures of some form, with 70% of
UK adults older than 75 years old wearing dentures
[2]. Denture wearing is also associated with socio-
economic deprivation and is more common in
women [3]. Many of these individuals have oral dis-
eases related to their denture wearing including den-
ture-induced stomatitis (DS), an inflammation of the
denture bearing mucosa [4]. Poor oral hygiene is
frequently observed within this group and several
factors can impact the onset of DS such as salivary
pH, smoking, sugar consumption, oral Candida, age
of denture, and, importantly, denture cleanliness [5].
The high prevalence of edentulousness and asso-
ciated DS highlight the importance of having consis-
tent effective denture care regimens which patients
can follow with confidence. However, the clinical and
laboratory evidence to support one regime over
another is not yet clear. To date, two systematic
reviews featuring a total of six randomised controlled
trials (RCTs) have been published [6,7]. These
reviews concluded that there was lack of evidence
on which to base guidelines and that further RCTs
are required. Recent guidelines based on the available
evidence suggest that removal of ‘bacterial biofilm’ is
of paramount importance to sustaining good oral and
systemic health and preventing DS [8]. These guide-
lines also advocate the reduction and maintenance of
low levels of microbial denture plaque through daily
soaking and/or brushing with an effective, non-abra-
sive cleanser, but there is a lack of clarity as to how
this is best achieved. Subsequent meta-analyses indi-
cate that in addition to existing methods, antiseptic
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mouthwashes, disinfection agents, natural antimicro-
bial substances, photodynamic therapy and micro-
wave disinfection could all be effective adjunctive
strategies for the management of denture hygiene [9].
Dentures are colonised when placed in the mouth
by a complex microbial plaque biofilm, which contains
numerous species of bacteria and fungi [10,11]. Plaque
development and microbial retention are aided and
enhanced by the irregular topographical surface
including cracks and crevices which can exist within
denture acrylic surfaces [12]. This environment also
provides protection from chemotherapeutic agents and
mechanical disruption methods, meaning that some
denture surfaces can carry up to 1011 microbes per
milligram of plaque [13,14]. Denture plaque biofilm
also represents a reservoir for potential opportunistic
respiratory pathogens [15].
There is a lack of consensus around suitable clean-
ing agents, with many denture wearers opting to use
toothpaste to mechanically clean their dentures.
However, this has been shown to induce abrasions,
resulting in physical defects on the denture acrylic
that may lead to enhanced microbial adhesion through
altered surface topography [14,16–18]. Guidance on
the frequency of cleansing is also lacking, although
laboratory and clinical studies report that the sporadic
use of denture cleansers facilitates the build-up of
mature denture plaque biofilms [19–21]. Many che-
motherapeutic interventions recommended are effec-
tive against planktonic oral bacteria, but unfortunately
live intact biofilms are able to persist even after treat-
ment with sodium hypochlorite [22]. These studies
taken collectively suggest that denture cleansing is
important, but more difficult to achieve than pre-
viously thought.
To shape and design an effective clinical trial,
appropriate laboratory models are needed to assess
in vitro the effect of novel approaches to denture
cleansing on the biofilm. Unfortunately, progress
here has been hampered by the fact that many den-
ture plaque treatment studies have focussed on
Candida albicans, primarily due to its role in den-
ture-related disease [4, 21–25]. Available data conser-
vatively estimates that at least 10-fold more bacteria
than yeasts colonise the surface of dentures [10],
clearly indicating that denture plaque has a polymi-
crobial and interkingdom composition [11]. Denture
plaque biofilm models, such as a recently described
11 species interkingdom model, are likely to be more
representative of the polymicrobial nature of the clin-
ical situation [26]. In this study, we sought to adopt a
bench-to-chairside approach to test the appropriate-
ness of routine daily denture cleansing methods com-
pared to intermittent methodologies. For this study
we have used denture cleanser tablets that are based
on generating hydrogen peroxide and peracetic acid.
Due to the chronology of the entire study two
different brand names were used (Corega and
Polident) based on the countries in which they are
marketed, and these products were used as per pack
instructions and were chosen to represent the lower
end of soaking practises that consumers typically use.
Material and methods
In vitro denture cleansing study
A denture plaque cleansing study and quantitative ana-
lysis of remaining viable cells was performed as pre-
viously described [26]. It was the aim to investigate
whether a sequential denture cleansing technique was
more advantageous than one treatment over the course
of a 5-day treatment regimen. Briefly, laboratory strains
were used to create a polymicrobial denture plaque
biofilm model based on the most dominant genera/
species identified from our recent denture microbiome
study [10]. Polymethylmethacrylate (PMMA) discs
were manufactured as described [27], providing the
physical substrates on which biofilms were formed.
The biofilms included Streptococcus mitis NCTC
12,261, Streptococcus intermedius ATCC 27,335,
Streptococcus oralis ATCC 35,037, C. albicans 3153A,
Actinomyces naeslundiiATCC 19,039,Veillonella dispar
ATCC 27,335, Rothia dentocariosa DSMZ 43,762,
Lactobacillus casei DSMZ 20,011 and Lactobacillus
zeae DSMZ 20,178. Initially, S. mitis, S. intermedius, S.
oralis and C. albicans were grown and standardised in
artificial saliva to 1 × 107 cells/mL. These were added to
each well of a 24 well plate (Corning Inc, New York,
USA) containing 13 mm2 PMMA discs (Chaperlin and
Jacobs Ltd, Southend-on-Sea, UK) and incubated aero-
bically at 37°C for 24 h. Next, standardised (1 × 107
cells/mL) A. naeslundii, V. dispar, R. dentocariosa, L.
casei and L. zeae were added to the preformed 24-h
biofilm and incubated at 37°C in 5%CO2 conditions for
a further 4 days. Spent supernatants were removed and
replaced with fresh artificial saliva daily.
Treatment regimens were either combinational
daily treatment of brushing with hard water, followed
by a daily 3 min soaking with a denture cleanser
(Polident®3 min denture cleanser; GSK Consumer
Healthcare, Weybridge, UK) (DC) for 5 consecutive
days (DT group), daily brushing with hard water inter-
mittent treatment (IT group) with DC on Day 1 and
Day 5 only, or they were left untreated and were
maintained in hard water corresponding to each treat-
ment arm, serving as positive controls (UT group).
Figure 1 shows a schematic of the treatment regimens.
Following each treatment, PMMA discs were incu-
bated in Dey-Engley neutralising broth (Sigma-
Aldrich, Gillingham, UK) for 15 min. PMMA discs
were then sonicated in 1 mL phosphate-buffered sal-
ine (Sigma-Aldrich, Gillingham, UK) at 35 kHz for
10 min to remove the biomass, as previously
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described [21]. For quantitative analysis, both colony-
forming unit (CFU) and quantitative live/dead PCR
were performed, as described previously [26].
For the former, 20 μL denture plaque sonicate was
transferred to a fresh microcentrifuge tube and serial
log10 dilutions were performed in phosphate buffered
saline, then 20 μL of each serial dilution was plated in
triplicate on brain heart infusion + 10% blood agar
plates (E&O Laboratories, Bonnybridge, UK), which
were incubated aerobically and anaerobically at 37°C
for 48 h [28]. The samples were also plated on
Sabouraud dextrose agar and incubated at 30°C for
48 h for yeasts. Following incubation, the number of
colonies was counted and represented as total viable
aerobes, anaerobes and yeasts.
Viability of the treated biofilms was also assessed
using live/dead PCR to enumerate the definitive and
relative composition of the biofilms, a technique that
has been shown to differentiate viable and dead cells
from multispecies oral bacteria biofilm models. Samples
were prepared as previously described, with some mod-
ifications [26]. In brief, 50 μM propidium monoazide
(PMA) was added to each sonicated sample and incu-
bated in the dark for 10 min to allow uptake of the dye.
Samples were then exposed to a 650 W halogen light for
5 min before DNA was extracted using the QIAamp
DNA mini kit, as per manufacturer’s instructions
(Qiagen, Crawley, UK). No PMA controls were included
for each sample to determine total biomass. The primers
used were previously published and are listed in Table 1.
Three independent replicates from each parameter were
analysed in triplicate using a MxProP Quantitative PCR
machine and MxPro 3000P software (Stratagene,
Amsterdam, Netherlands). Samples were quantified to
calculate the colony-forming equivalent (CFE) based
upon a previously established standard curve methodol-
ogy of bacterial CFU ranging from 1 × 103 to 108 CFU/
mL [15]. Melting curve analysis was performed for all
primer sets to ensure a single peak, which was indicative
of primer specificity.
Data analysis
Data distribution, graph production and statistical
analysis were performed using GraphPad Prism (ver-
sion 5; La Jolla, CA, USA). After assessing whether
data conformed to a normal distribution, One-way
Analysis of Variance (ANOVA) and t tests were used
to investigate significant differences between inde-
pendent groups of data that approximated to a
Gaussian distribution. A Bonferroni correction was
applied to the p value to account for multiple
1 2 3 4 5






Figure 1. Sequential treatment of denture biofilm protocol.
Table 1. Primer sequences for denture biofilm species.
Target Primer sequence (5ʹ-3ʹ) Reference
16S F – CGCTAGTAATCGTGGATCAGAATG
R – TGTGACGGGCGGTGTGTA
[26]
18S F – CTCGTAGTTGAACCTTGGGC
R – GGCCTGCTTTGAACACTCTA
[26]
Streptococcus spp. F – GATACATAGCCGACCTGAG
R – CCATTGCCGAAGATTCC
[52]
A. naeslundii F – GGCTGCGATACCGTGAGG
R – TCTGCGATTACTAGCGACTCC
[52]
R. denticariosa F – GGGTTGTAAACCTCTGTTAGCATC
R – CGTACCCACTGCAAAACCAG
(53)
V. dispar F – CCGTGATGGGATGGAAACTGC
R – CCTTCGCCACTGGTGTTCTTC
[52]
L. casei F – TGCACTGAGATTCGACTTAA
R – CCCACTGCTGCCTCCCGTAGGAGT
(54)
L. zeae F – TGCATCGTGATTCAACTTAA
R – CCCACTGCTGCCTCCCGTAGGAGT
(54)
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comparisons of the data. Non-parametric data were
analysed using the Mann-Whitney U-test or the
Kruskal–Wallis test with a Dunn’s post-test to assess
differences between independent sample groups.
Statistical significance was achieved if p < 0.05.
Principal Component Analysis (PCA) of the log (n)
of CFUs of bacterial and yeast growth and CFEs of
live bacteria and yeast after treatment were per-
formed with R using in-built functions. Clustering
(three clusters) was performed using the partitioning
around mediods (pam) algorithm, a more robust
version of k-means clustering, using the R package
‘cluster’. Visualisation by the package ‘ggplot2ʹ was
utilised to provide figures.
In vivo denture cleansing study
To assess the impact of daily or weekly DC on denture
microbial count, composition, plaque and stain accumu-
lation, a clinical trial was designed and carried out. This
was a single-centre, randomised, controlled, examiner-
and analyst-blind, crossover study conducted at Glasgow
Dental Hospital and School, UK. The protocol was
approved by an Independent Ethics Committee (West
of Scotland Research Ethics Committee 3; Ref:16/WS/
0092) and the study was conducted in accordance with
the Declaration of Helsinki, the International Conference
on Harmonisation of Technical Requirements for
Registration of Pharmaceuticals for Human Use and
local laws and regulations. All participants provided
written informed consent prior to screening, demon-
strated understanding of the protocol and were consid-
ered willing, able and likely to comply with all study
procedures. This study was registered at ClinicalTrials.
gov: NCT02780661. There was one amendment to the
protocol to widen inclusion criteria to aid recruitment,
this was not predicted to influence study outcomes.
Participants
Participants in general good health, aged between 18 and
84 years inclusive, were recruited through self-referral
and identification at treatment clinics at Glasgow Dental
Hospital and School. Participants were required to have a
completely edentulous maxillary arch restored with a
conventional, full acrylic based, complete denture. The
mandibular arch could be dentate, partial or full edentu-
lous and could be restored with a stable complete, partial
or implant supported denture. Maxillary dentures
needed to be of a well-made design and construction,
as assessed by the study examiner and moderately well-
fitting at the screening visit according to the Kapur Index
[29], Olshan Modification [30]: retention score > 2,
stability score > 2. Exclusion criteria included pregnancy;
breastfeeding; known/suspected intolerance or hypersen-
sitivity to study materials or ingredients; a serious, severe
or unstable medical condition that would make the
participant unlikely to fully complete the study; an
implanted cardiac pacemaker; taking a daily dose of
medication that might interfere with the participant’s
ability to perform the study or might affect efficacy
assessments. Specific dental exclusion criteria included:
a clinically significant or relevant oral abnormality that,
in the investigator’s opinion, could affect study participa-
tion; recent (within 30 days) gingival/oral surgery.
Study design and treatment
Study flow is detailed in Figure 2. At screening,
participants provided written informed consent and
eligibility was assessed. They received a dental pro-
phylaxis and a denture prophylaxis of the maxillary
complete denture; zero plaque and stain scores were
confirmed by post-prophylaxis assessments. At the
first study visit (Day 0) participants were assigned
to a study treatment sequence order (1:1) in accor-
dance with the randomisation schedule provided by
the Biostatistics Department of GSK Consumer
Healthcare. Randomisation numbers were assigned
in ascending numerical order as each participant
was determined to be fully eligible and consented
for inclusion. All participants used supplied alkaline
peroxide-based denture cleansing tablets (Corega®
Figure 2. Study flow.
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Tabs Dental Weiss für Racher [Denture Whitening
for Smokers], German marketed product). The Daily
Use group used one tablet per day (with supervised
use at the site on Days 0, 3 and 7). The Weekly Use
group used one tablet on Day 7 (supervised use at site
on Day 7).
Dentures were soaked in a cup of 150 mL warm
water with a cleanser tablet for 15 min, brushed for
30 s using the solution, then rinsed under running
water for 10 s. At home, the Daily Use group
repeated this procedure for the upper denture in
the evening while the Weekly Use group carried
out the procedure in warm water only. Both groups
left dentures to soak overnight in 150 mL water. The
lower denture, if present, was cleaned as usual but
separately from the upper denture. Cleaning of the
upper denture was not permitted in the morning; the
lower denture could be cleaned as usual. Participants
returned on Days 3 and 7. Following a washout
period (7 ± 3 days) participants returned for treat-
ment period 2, as described above including an
initial denture and dental prophylaxis. Participants
refrained from smoking, including e-cigarettes and
the use of chewing tobacco or other tobacco pro-
ducts for the duration of the study. They could not
use any other denture cleaners or regimens to clean
their upper dentures. Participants were asked not to
use denture fixative, xylitol-containing or oral-care
type chewing-gum for the duration of the trial as
these could impact hygiene parameters.
Examiners (clinical and laboratory scientists) and
data analysts were blinded to treatment allocation.
Examiners were not allowed to be in the room
where test products were stored or allocated.
Additionally, dispensing staff were not involved in
any effectiveness assessments. Examiners were cali-
brated prior to commencement of the trial.
Microbial sampling
To collect samples from the tissue-fitting surface of
the maxillary denture for microbiological analysis, the
denture was sampled in four quadrants lateral to the
midline and corresponding to the palatal rugae
(Figure 3). Pre-prophylaxis and pre-treatment sam-
ples were taken from the left rough (A) and left
smooth (D) denture side. Post prophylaxis and post-
treatment samples were taken from the right rough
(B) and right smooth (C) denture surface.
A pre-sterilized 10 mm filter paper disc (Sigma-
Aldrich, Gillingham, UK) was lightly pressed against
the allocated quadrant for 20 s prior to aseptic
removal. Two discs, of the allocated quadrants
(depending on the time point), were pooled and
processed appropriately for microbiology cultures
(CFU/disc) to assess microbial counts (aerobic bac-
teria, anerobic bacteria and C. albicans), and for
qPCR analysis to assess denture microbial composi-
tion, as described previously [26]. To investigate the
microbial counts and microbial composition on the
whole maxillary denture, on Day 1 (pre-prophylaxis)
and Day 7 (post-treatment) the maxillary denture was
placed in a sterile bag with 50 mL PBS and placed in a
sonic bath for 15 min at 35 kHz. This procedure
removed microbes adhered to all areas of the denture.
The resulting samples were processed appropriately
for microbiology cultures (CFU/denture) and for
molecular microbial analysis by qPCR (CFE/denture),
as described previously [26].
Clinical assessments
Denture plaque was assessed on three areas sepa-
rately: fitting surfaces, polished surfaces and denture
teeth (facial/buccal and palatal) based on the modifi-
cation of the Clinical Categorization of Denture
Cleanliness Index [31], where 0 = No visible plaque;
no matter adherent to the side of the dental probe on
light scraping; 1 = No visible plaque; matter adherent
to the side of the dental probe on light scraping;
2 = Deposits of plaque just visible on careful exam-
ination without need to confirm by scraping;
3 = Deposits of plaque ‘clearly visible’; 4 = Gross
plaque deposits (‘velvet appearance’). For a given
denture area under examination, the highest score
of that area was recorded.
Denture stain was also assessed on these areas, by
modification of the Denture Cleanser Index [32]. The
stain scale was related to the percentage of the surface
covered in stain where 0 = No staining detectable;
1 = Little staining (<25% of surface stained);
2 = Moderate staining of surface (25–50% of surface
stained); 3 = Severe staining of surface (>50% of
surface stained).
Safety
Adverse events (AEs) were collected from the start of
the denture and dental prophylaxis at the Screening
Visit until 5 days following last administration of the
Figure 3. Quadrants used for sampling.
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study product. Incidents were documented from the
Baseline visit (Visit 2). Oral soft tissue examinations
were performed at all baseline visits pre-prophylaxis
or pre-treatment. The safety population was defined
as all participants who were randomised and received
at least one dose of study treatment during the study.
Evaluation criteria and data analysis
As variation and treatment effect were unknown, a
formal sample size calculation was not possible. A
total of 17 participants was determined to be suitable
to assess effectiveness and safety of treatment pro-
ducts. The primary population for efficacy assessment
was the intent-to-treat (ITT) population, defined as
all participants who were randomised, received at
least one dose of study treatment and provided at
least one post-baseline assessment of microbial
count from disc sampling. The per protocol (PP)
population was defined as all participants in the ITT
population who had at least one assessment of effi-
cacy considered unaffected by protocol violations.
The primary objective was to evaluate and com-
pare change from baseline in microbial count from
denture disc samples of the Daily Use and Weekly
Use groups on Day 7, with comparison on Day 3 as a
secondary objective. Exploratory objectives included
evaluation and comparison of the denture sonicate
microbial count on Day 7 and, on Days 3 and 7
plaque levels, microbial composition from disc sam-
ples and stain levels on the maxillary denture. All
endpoints were tested under the general hypotheses
of a treatment difference between Daily and Weekly
product use. All statistical analyses were conducted
using Statistical Analysis System (SAS) version 9.2.
The three microbial counts (aerobic bacteria
microbial count, anaerobic bacteria microbial count
and Candida microbial count) were analysed sepa-
rately for both treatment regimens at Days 3 and 7
compared to pre-treatment Day 0. Microbial counts
were log transformed (base 10) prior to any analysis
being performed. To be able to analyse all samples, if
no microbes were retrieved (‘0ʹ values), a constant
(+1) was added to all values prior to log transforma-
tion. Changes from baseline were analysed using an
analysis of covariance (ANCOVA) model with treat-
ment and period as fixed effects, participant-level
(mean across treatment periods) and period-level
pre-treatment (on Day 0) baseline scores (with the
same transformation) as covariates. To allow model
estimates to be representative of the studied popula-
tion, participant was included in the model as a ran-
dom effect. Confidence Intervals (CIs) and p-values
were calculated for the difference between the treat-
ments (Daily use vs Weekly use). Model assumptions
were investigated, no assumptions were violated.
Microbial counts at Day 7 and denture plaque
levels at Days 3 and 7 compared to Day 0 pre-treat-
ment were calculated with each endpoint using an
ANCOVA as above. Model assumptions were inves-
tigated, no assumptions were violated. Microbial
composition at Days 3 and 7, assessed by qPCR
from disc samples, was represented for both treat-
ments in a stacked bar chart as percentage of each
microbial group. The sum of the eight oral microbial
groups analysed was considered as 100%. Denture
stain levels at Days 3 and 7 on tissue fitting surfaces,
polished surfaces and denture teeth stain score were
analysed separately as a change from baseline to
compare between treatment regimens (Daily use
and Weekly use).
Examiner repeatability
At each visit, for a random sample of participants, stain
and plaque assessments were repeated by the examiner
to check consistency in measuring plaque and stain
levels on the denture surfaces. For each parameter of
stain and plaque assessments, a Fleiss-Cohen weighted
kappa coefficient (κ), along with the 95% CI was calcu-
lated for the repeatability analysis for each denture sur-
face (tissue fitting surfaces, polished surfaces, denture
teeth). Reliability was deemed excellent if κ>0.75; fair to
good if 0.4≤κ≤0.75; poor if κ<0.4
Results
Quantitative analysis of in vitro denture plaque
biofilm
The in vitro analysis of different denture treatment
regimens on multispecies denture plaque biofilms
was carried out over the course of 5 days. Three
groups were included: untreated biofilms as a positive
control (UT), daily brushing followed by denture
cleansing (DT) and intermittent denture cleansing
(IT). Total aerobes, anaerobes and yeasts were initi-
ally quantified using CFU analysis over 5 days
(Figure 4). For the DT group, no viable CFUs were
detectable (ND) on any day for aerobes, anaerobes
and yeasts, whereas for the IT group, viable bacteria
were detected on Days 2, 3, 4 and 5 (approximately
103 to 105 CFU/mL), and on Days 2, 3 and 4 for
yeasts (approximately 103 to 104 CFU/mL). No sig-
nificant changes in overall microbial levels were
observed in this time frame for the UT group, with
consistent levels of 108 and 106 CFU/mL detected for
bacteria and yeasts, respectively (data not shown).
Both the DT and IT groups showed a statistically
significant reduction in CFU’s for aerobes, anaerobes
and yeasts (p < 0.001) compared to the UT group,
though DT was consistently and statistically signifi-
cantly more effective than IT (p < 0.001). To visually
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illustrate the overall effects of the treatment regimens,
a PCA analyses was performed (Figure 5). Clustering
demonstrated three independent clusters between the
treatments as highlighted by the ellipses and colored
clusters. PC1 and PC2 are displayed with PC1 dis-
playing over 94% of the variation between samples,
the variation along this component distinguishes
between the treatment types.
Given that total viable cell counting is prone to
inaccuracy (e.g. clumps of cells), and the possibility
for the carry-over of actives, despite neutralisation,
then a quantitative PCR was employed as an adjunc-
tive assay to supplement these observations. For total
bacteria retained on the PMMA surface following
treatment (Figure 6), the number of bacteria was
significantly lower in both the IT and DT groups
compared to the untreated control by approximately
3 log10 (p < 0.001), though no discernible differences
were observed in retained bacteria between these
groups (data not shown). The number of yeasts iso-
lated from the discs shows a similar pattern to that of
the bacteria, in that by comparison with the UT
group there were significantly fewer yeast cells in
both the DT and IT groups, with an approximately
1 log10 reduction (p < 0.001), though again there were
no differences between DT and IT groups. Live qPCR
analysis was also performed to assess how many of
the retained cells were viable, based on whether cell
membranes were compromised or not. This showed
that despite these treatments, approximately 1 × 104
and 1 × 103 CFE/mL of bacteria and yeasts, respec-
tively, remained viable through Days 1 to 5, irrespec-
tive of treatment group (data not shown).
To assess whether any of the treatment regimens
impacted the composition of the denture plaque bio-
films, changes in the individual species contribution to
Figure 4. Daily CFU/mL counts of A) aerobic bacteria, B) anaerobic bacteria and C) total yeast count (±standard deviation) post
treatment.
Figure 5. Principal component analysis showing different in vitro treatment outcomes associated with total and viable cell
populations.
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each biofilm were investigated over the 5-day time
course. The total cell count was quantified and con-
verted into a proportion of the overall biofilm to deter-
mine the contribution of each species. Interestingly, it
was observed that the UT group showed a number of
changes over the 5 days, with V. dispar, A. naeslundii
and Streptococcus species dominating the biofilm, with
a notable increase in V. dispar at Days 4 and 5 (Figure 7
(a)). Reciprocally, a reduction in R. dentocariosa, C.
albicans, L. zeae and L. casei, was observed daily as the
biofilms matured. The DT group showed a biofilm
dominated by A. naeslundii, with increasing propor-
tions of Streptococcus species (Figure 7(b)), though the
IT group was initially dominated by A. naeslundii,
followed by Streptococcus species (Figure 7(c)).
Overall, these data showed that different interventions
have the capacity to alter denture plaque composition,
in a treatment dependent manner.
Figure 6. Daily CFE counts of (a) total bacteria and (b) total yeasts post treatment (±standard deviation).
Figure 7. Microbial composition as assessed by qPCR from in vitro denture disc samples. (a) Untreated [UT], (b) Denture cleanser
[DT], (c) Brushing [IT].
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Quantitative analysis of in vivo denture plaque
biofilm
Clinical
A total of 25 participants were screened, with a total of
19 participants randomized to a treatment sequence.
There were no participant withdrawals with all 19
randomized participants completing the study. There
was one protocol violation in the Daily use regimen
and one in the Weekly use regimen treatment periods,
which led to data exclusion. Of the 19 participants the
majority were female (n = 12, 63.2%) and white
(n = 19, 100%), with a mean age of 68.7 years (SD
5.10, range 60–75 years). At baseline (Day 0, pre-
treatment), the transformed microbial counts [Log10
(Count+1)] were slightly higher in the Weekly use
treatment at 2.27 Log10(CFU/disc) compared to 2.04
for Daily use for aerobic bacteria. These values for
anaerobic bacteria were 2.47 and 2.07, respectively.
Microbial counts
A reduction from baseline in both aerobic and anae-
robic bacteria in the denture disc samples was
observed on Day 7 for both treatments, resulting in
values of adjusted mean values of 0.26 Log10(CFU/
disc) and 1.06 Log10(CFU/disc) aerobic bacteria in
the Daily Use and the Weekly use treatment respec-
tively, and 0.50 Log10(CFU/disc) and 0.93 Log10
(CFU/disc) anaerobic bacteria for each treatment,
respectively (Figure 8). A statistically significant dif-
ference between treatments was observed for aerobic
bacteria microbial count at Day 7, with a greater
reduction observed for the Daily use treatment
(Table 2) (−0.86 adjusted mean treatment difference,
p-value 0.0144). For the anerobic bacteria, a treat-
ment difference was observed in favour of the Daily
use treatment; however, this difference was not sta-
tistically significant (−0.48 adjusted mean treatment
difference, p-value 0.1879). C. albicans cultured from
disc samples were mostly zero and were therefore not
further analysed (data not shown).
At Day 3, a reduction from baseline in aerobic and
anaerobic bacteria was observed for the Daily use
treatment, resulting in adjusted mean values of 0.31
and 0.33 Log10(CFU/disc) respectively. Subjects in the
Weekly use treatment, who did not use the denture
cleanser tablet but cleaned their denture with water
instead, showed an increase in both microbial counts.
Aerobic bacteria increased to 2.63 Log10(CFU/disc)
while anaerobic bacteria increased to 3.55 Log10
(CFU/disc). A statistically significant between treat-
ment difference was observed for aerobic and anae-
robic bacteria microbial count at Day 3 with the
greater reduction observed for the Daily use treat-
ment (−2.32 adjusted mean treatment difference,
p-value 0.0002 for aerobic bacteria and −3.22,
p-value <0.0001 for anaerobic bacteria). Following
the Daily use treatment regimen, a high proportion
of subjects had no microbial counts at Day 3 (17 out
of 19 for both aerobic and anaerobic bacteria) while
in the Weekly use treatment regimen no microbes
were retrieved from fewer subjects (seven out of 19
subjects for aerobic bacteria and four out of 19 for
anaerobic bacteria).
With regards to exploratory objective, denture
sonicate microbial samples were collected only at
Day −1 visit (Screening visit) before initial prophy-
laxis (pre-prophylaxis) and at Day 7 (post-treatment).
No statistically significant between treatment differ-
ence was observed for aerobic or anaerobic bacteria
microbial count at Day 7 in the denture sonicate
samples (Table 2). C. albicans microbial count from
both time points and treatments were retrieved at
lower numbers than aerobic or anerobic bacteria. A
between treatment difference was observed in favour
of the Daily use treatment; however, this difference
was not statistically significant (−0.60 adjusted mean
treatment difference, p-value 0.325).
Microbial composition
Microbial composition by treatment and visit was
assessed using specific primers targeting bacteria
Figure 8. (a) Aerobic bacteria and (b) Anaerobic bacteria microbial count Log10 (CFU/disc) by visit and treatment from denture
disc samples (±standard error) (ITT population).
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known to be associated with dentures, as described
above. A stacked bar chart is presented for their
relative abundance, considering as a 100% the sum
of the eight microbial groups targeted (Figure 9).
There was no formal statistical analysis performed
for the microbial composition data. A dominance of
V. dispar and Streptococcus species was observed at
the different time points and for both treatments
(ranging between 57 and 77% and 15 and 41%,
respectively). A. naeslundii was detected with both
treatments and visits but in lower relative abundance
(ranging between 1 and 9%). R. dentocariosa, L. casei
and Candida species were only minor contributors to
the microbial composition of the dentures (in the disc
samples), detected at less than 1%. L. zeae was not
detected in any of the samples. In the Weekly use
treatment group, a slight increase in Streptococcus
species was detected from Baseline (pre-treatment)
to Day 3 and Day 7 (post-treatment) and a slight
decrease in V. dispar and other minor groups.
However, no overall evident changes in microbial
composition were observed either for the Daily use
or the Weekly use treatment, with both having a
dominance of V. dispar and Streptococcus species.
Denture plaque and stain scores
Overall, low plaque scores were observed on all the
denture surfaces, particularly on the polished surfaces
(Table 3). Examiner repeatability for plaque was excel-
lent with a weighted kappa of 0.968 [95% CI
0.922,1.00]. Despite the overall low plaque scores, a
decrease following Daily use of the denture cleanser
was observed at Days 3 and 7, while the Weekly use
treatment regimen led to small changes depending on
Day and denture area examined (Figure 10). At Day 3
there were differences observed in favor of the Daily
use treatment for the three surfaces; however, these
differences were not statistically significant. At Day 7,
a statistically significant between treatment difference
was observed for denture teeth and for tissue fitting
surfaces with the greater reduction observed for the
Daily use treatment in both surfaces (−0.54 adjusted
mean treatment difference, p-value 0.0211 for denture
teeth; −0.57, p-value 0.0320 for tissue fitting surface)
Stain levels were very low throughout the study,
particularly at baseline where most of the surfaces
had a ‘no staining detectable’ score. Overall, at Day 7
for the three surfaces there was a difference observed
in favour of the Daily use treatment. However, these
Table 2. Statistical analysis of change from baseline in aerobic bacteria and anaerobic bacteria microbial counts (CFU/disc) from
denture disc (DDisc) and denture sonicate (DSon) samples (ITT Population).
Change from baseline Treatment comparison
Daily use Mean (SE) Weekly use Mean (SE) Difference (95% CI) p-value Ratio (95% CI)
Aerobic bacteria (post treatment)
DDisc Day 3 −1.85 (0.39) 0.47 (0.39) −2.32 (−3.43, −1.20) 0.0002 0.005 (0.0004, 0.0628)
DDisc Day 7 −1.92 (0.32) −1.06 (0.32) −0.86 (−1.53, −0.19) 0.0144 0.137 (0.0295, 0.6369)
DSon Day 7 −0.36 (0.13) −0.48 (0.13) 0.12 (−0.257, 0.505) 0.5118 1.33 (0.55, 3.20)
Anaerobic bacteria (post treatment)
DDisc Day 3 −1.94 (0.38) 1.28 (0.38) −3.22 (−4.24, −2.19) <.0001 0.001 (0.0001, 0.0064)
DDisc Day 7 −1.80 (0.33) −1.31 (0.32) −0.48 (−1.23, 0.26) 0.1879 0.328 (0.0589, 1.8257)
DSon Day 7 −0.35 (0.13) −0.42 (0.14) 0.07 (−0.33, 0.46) 0.7316 1.17 (0.47, 2.88)
C. albicans (post treatment)
DSon Day 7 −0.69 (0.44) −0.08 (0.45) −0.60 (−1.86, 0.66) 0.3250 0.25 (0.01, 4.53)
Difference is first named treatment minus second named treatment such that a negative difference favours the first named
Figure 9. Microbial composition as assessed by qPCR from denture disc samples (ITT population).
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differences were very small and not statistically signif-
icant for any of the three surfaces (data not shown).
Safety results
Overall, 28 treatment emergent AEs (TEAEs) were
reported by 13 (68.4%) participants, 14 in each of the
treatment groups. There were 21 oral TEAEs reported
by 12 participants (63.2%) (10 in the Daily Use and
11 in the Weekly Use groups). None of the TEAEs
were considered related to treatment. All TEAEs were
mild or moderate in nature and all but ‘Lip injury’
had resolved by study end. There were no serious AEs
or incidents reported and no participants withdrew
from the study due to AEs. The use of the denture
cleanser tablet was shown to be generally well toler-
ated in the study.
Discussion
While there is limited evidence on how denture care
should be implemented [6,7], the guidelines are clearer
on what should not be done [8]. Cleaning in boiling
water and storing the dentures dry should be avoided
to minimize physical warping. The storage solution
should be changed frequently to prevent microbial
overgrowth within the water. Prolonged exposure to
sodium hypochlorite/bleach containing products
should also be avoided due to its detrimental impact
on denture materials, particularly metals [33]. The use
of microwave disinfection in combination with den-
ture cleansers and brushing has also been shown to
disinfect dentures in vivo [34], though microwaves
may also physically distort denture acrylics [35]. A
number of unconventional approaches to denture
care, including soaking in vinegar, baking soda,
sodium chloride (table salt) and liquid soaps, were
identified in a recent study [36]. Many of these reme-
dies are lacking in either efficacy and/or material
compatibility [33]. Nevertheless, without proper pro-
fessional advice many denture wearers may well con-
tinue these alternative practices.
Collectively the current evidence we have, which
in many instances remains weak, highlights the need
for improved denture cleansing techniques capable of
dealing with a range of bacteria, in addition to highly
tolerant candidal cells. Disruption of the denture
biofilm is also critical to improving oral health. This
may be achieved either through mechanical means
such as a brush or using sonic cleaning devices which
may be a more effective method of cleansing and
decolonising dentures. Alternative strategies may
include chemicals and enzymes capable of digesting
and disaggregating biofilms, which could allow
improved penetration and activity of agents in cracks,
crevices and pores. On current evidence, mechanical
disruption coupled with effective antimicrobial agents
is likely to be the most desirable option.
PMMA is the primary denture material of choice,
though this has an uneven surface that results in a
heterogenous topography that yeasts and bacteria can
co-colonise, forming biofilms and escaping from den-
ture cleansing therapies [21,37,38]. Investigations to
determine optimal methods for cleaning dentures
have focussed on the various physical and chemical
cleansing techniques, both individually and in com-
bination. However, most of these investigations eval-
uate treatment over a short period of time and
therefore do not accurately simulate an optimal den-
ture routine clinically [8,39,40]. Daily denture cleans-
ing treatment of C. albicans biofilms has been
previously investigated, with results indicating that
despite a significant reduction in viable C. albicans
cells, a residual reservoir of yeast cells remained,
indicative of ineffective cleansing [21,41,42]. A lim-
itation of these studies was the use of a single species
biofilm model, as this is not reflective of the poly-
microbial denture environment. The present study
aimed to address this by developing a more complex
model that would allow assessment of repeated, long-
itudinal treatments as well as physical and chemical
treatment modes.
Quantitative analysis of different denture treat-
ment regimens on multispecies in vitro denture pla-
que biofilms was carried out over the course of
5 days. Results indicated that regular daily cleaning
provided a significantly greater benefit than inter-
mittent cleaning, even with the use of brushing
Table 3. Statistical analysis of change from baseline in plaque score in denture teeth, tissue fitting surfaces and
polished surfaces (ITT Population).
Change from baseline Treatment comparison
Daily use Mean (SE) Weekly use Mean (SE) Difference (95% CI) p-value
Denture teeth (post treatment)
Day 3 −0.65 (0.20) −0.30 (0.20) −0.35 (−0.92, 0.23) 0.2307
Day 7 −0.79 (0.15) −0.26 (0.15) −0.54 (−1.99, −0.09) 0.0211
Tissue fitting surfaces (post treatment)
Day 3 −0.58 (0.20) −0.05 (0.20) −0.52 (−1.11, 0.07) 0.0765
Day 7 0.52 (0.18) 0.05 (0.18) −0.57 (−1.095, −0.05) 0.0320
Polished surfaces (post treatment)
Day 3 −0.30 (0.05) −0.28 (0.05) −0.02 (−0.15, 0.12) 0.7875
Day 7 −0.30 (0.16) 0.09 (0.16) −0.39 (−0.86, 0.07) 0.0953
Difference is first named treatment minus second named treatment such that a negative difference favours the first named
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together with the chemical disinfection. The results
showed that despite active treatments of denture
material, significant quantities of microorganisms
were retained on the PMMA surface, that could
only be released by sonication. Thus, although a
considerable number of microbes remained on the
discs post cleansing, the treatments employed were
significantly effective given the extensive reduction
in the overall microbial burden. Live qPCR results
suggest that the denture plaque biofilm may contain
the dormant persister cell phenotype that are
unaffected by treatments, but cannot necessarily be
cultured. Overall, these data suggest that denture
biofilm composition is dependent on whether and
how the biofilms are treated, which largely agrees
with our previous studies [21,26]. However, this
model benefits from its inception and design based
on the first reported denture plaque microbiome
[10]. This has facilitated us to use this as a robust
first line screening tool capable of discerning quan-
titative differences in denture plaque biofilms in a
reproducible manner.
Figure 10. Raw means plaque score on (a) Denture teeth, (b) Tissue fitting surfaces and (c) Polished surfaces (±standard error)
(ITT population).
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The clinical study also followed a similar pattern
with regard to the microbial count reduction between
daily vs intermittent cleaning. Several studies have
demonstrated the ability of alkaline peroxide based
denture cleansers on reducing denture plaque biofilm
[43,44]. The current study is first of its kind evaluat-
ing the impact of daily vs intermittent (once weekly
cleaning) using alkaline peroxide based denture
cleanser tablets.
A statistically significant greater reduction in aero-
bic bacteria microbial count was reported for the Daily
use treatment regimen at Day 7 and in aerobic and
anaerobic bacteria at Day 3 in comparison with the
Weekly use treatment regimen. At Day 3 the aerobic
and anaerobic microbial count in the Weekly use
treatment was higher than at Day 0, indicating that
the microbial biofilm grew from baseline when parti-
cipants cleaned their dentures daily with water. At Day
7, where participants in both treatment regimens used
the denture cleanser tablet, the aerobic and anaerobic
bacterial count was reduced from baseline in both
treatments. The result at Day 3 presumably reflects
the antimicrobial activity delivered from the denture
cleanser tablet, in comparison with water. However,
the differences observed at Day 7 are intriguing since
both groups had received identical treatments imme-
diately prior to sampling. The data suggest that the
biofilm developed in the weekly treatment group was
more resistant to a single treatment with denture
cleanser in comparison to the biofilms developed in
the daily treatment group. This is in accordance with
the results seen in the in vitro element of the present
study, and in many other studies of mature biofilms
from oral and other sources. It provides a microbial
line of evidence to support previous clinical studies
that have suggested regular cleaning of dentures to be
beneficial to overall oral health [6,7]. Soaking alone in
a denture cleanser may not be sufficient for adequate
plaque removal [45], and is in line with the widely held
belief around mechanical cleaning methods being
important for physical plaque removal. Some studies
have demonstrated an additional benefit linked to use
of denture cleanser tablets on plaque removal com-
pared to brushing alone. Sheen and colleagues demon-
strated use of alkaline peroxide based cleanser resulted
in 42% reduction (p = 0.0014) in plaque levels after
2 weeks of use compared to brushing with water [46].
Despite the relatively low denture plaque scores
throughout this study, a statistically significantly greater
reduction in denture teeth and tissue fitting surfaces
plaque scores were found for the group using the Daily
use treatment regimen compared to the Weekly use
treatment at Day 7. Nishi et al (2012) collected denture
plaque from denture wearers and analysed the effect of
denture brush use, cleansing frequency and cleaning
solution [47]. They concluded that the use of brush
was associated with lower amounts of microbes and
that, unsurprisingly, daily use was better than monthly
use. In the general population they did not find a
difference between daily and 3–4 times per week, but
in those patients who were in nursing homes daily
cleaning was the most effective. It is possible that these
most vulnerable patients are unable to clean sufficiently
themselves and our study would confirm that daily
cleaning is advisable. Our results are also in agreement
with the small clinical study carried out by Sheen et al
(2000), which showed that denture plaque levels could
be reduced using a daily brushing technique, but that
the addition of an active cleanser reduced the rate of
plaque formation and was more effective than water
and brushing alone [46]. Moreover, results of the pre-
sent study correlate with the conclusion of Kiesow et al
(2016), who reported that specialist denture cleanser
tablets provide a good combination of microbial effi-
cacy, while also maintaining material compatibility
[33]. The use of denture cleansers was also shown to
lead to a significant reduction of microbial burden
compared to a mouthwash [48]. This study, alongside
the preceding evidence, has in part addressed the inade-
quacies in the literature that was concluded from pre-
vious systematic reviews [6,7]. Indeed, these data
provide greater evidence that frequent use of denture
cleansers is an effective strategy for supporting a low
microbial bioburden that logically will maintain muco-
sal health. To further define and evolve our understand-
ing of mucosal health we have developed techniques to
investigate and evaluate microbial population
dynamics. This approach may have translational bene-
fits for improving existing denture cleansers developed
to target specific groups of pathogenic denture plaque
microorganisms.
The denture microbial composition was investigated
from the disc samples by a qPCR targeted approach at
Days 0, 3 and 7. Eight microbial groups were selected
based on findings from a previous microbiome high
throughput sequencing study of denture wearers [10].
In the present study a relative dominance of V. dispar
and Streptococcus species was observed in both treatment
groups and at all time points, with othermicrobial groups
contributing in smaller proportions. No apparent differ-
ence between treatments were observed. Streptococcus
andVeillonella have been documented as early colonizers
and dominant microbes in healthy oral biofilms [49–51]
and have been reported asmajor components of dentures
in participants without stomatitis [10,52]. Actinobacteria
spp. have been reported as abundant components of the
denture’s microbiome [10]; however, in this study they
were present in a relative low abundance (<10%). This
study would benefit from a full microbiome analyses,
though whether these data would add value in terms of
driving evidence for the best treatment regimens remains
to be seen. Our qPCR approach provides an intermediate
and more economical approach to assessing changes in
microbial dynamics.
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Conclusions
The present study shows how basic science understand-
ing has enabled the development of an in vitro denture
plaque model system that mimics the development of
plaque on dentures in the mouth. Treatment with den-
ture cleansers on a regular, daily basis in both an in vitro
model and in a clinical study of denture wearers was
more effective in reducing microbial numbers and pla-
que scores in comparison with intermittent treatments.
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